4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-25-102606
Director bought 454,545 shares at $22.00 ($9,999,990)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2025-10-23 | Purchase | +454,545 | $22.00 | $9,999,990 | 3,914,458 | I: show line 1 in the form |
| Open-market purchases · 454,545 sh · avg $22.00 · $9,999,990 | |||||||
Loading xslF345X05/tm2529526-1_4seq1.xml…